Gilly Bernard

Biography

Bernard Gilly is one of our founders, and has served as our Chief Executive Officer since GenSight's creation in 2012.  Bernard has over twenty years of experience in the financial and pharmaceutical sectors. He co-founded several high potential start-ups, developing disruptive technologies in the biotech and medtech fields. He is currently non-executive Chairman of Pixium Vision (since 2011), EyeTechCare (2012), Gecko Biomedical (2013) and Chronocam (2015). From 2005 to 2009, he founded and was Chairman and Chief Executive Officer of Fovea Pharmaceuticals, a privately owned biotech company, which was acquired by Sanofi in 2009. After the acquisition, he became Senior Vice-President of the Ophthalmology Division of Sanofi until 2012. Prior to Fovea, Dr. Gilly was a partner at Sofinnova Partners from 2000 to 2005. From 1992 to 2000, he was Chief Executive Officer of Transgene. At that time, he took the company public on the NASDAQ and the Nouveau Marché in France, raising over $120M in 1998.  Prior to that, he was VP of R&D at Pasteur Mérieux Connaught (now Sanofi Pasteur). Dr. Gilly received an engineering degree from Ecole Nationale d’Agronomie and a Ph.D. from Université de Rennes.

Research Interest

Bioinformatics & Systems Biology